Subacute transverse myelitis of possible vasculitic origin after SARS-CoV2 and Varicella-Zoster virus infections: a case report
Authors (first, second and last of 6)
Collection
COVID-19
The ongoing global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused hundreds of millions of infections, and millions of deaths have been attributed to the disease. Publishing research on Covid-19 is crucial to understand how it affects patients, to combat the disease, and to ultimately overcome this global health emergency.
The Journal of Neurology has dedicated an article collection to neurological research in connection to Covid-19. This article collection aims to gather all articles relevant to neurological disease and Covid-19 in one place, so that researchers and clinicians can easily access reviews, original articles, short commentaries and case reports on the subject.
The article collection on Covid-19 will remain open; manuscripts on Covid-19 can be submitted freely to the journal and will be added to the collection upon publication. Submissions on Covid-19 are subject to the rigorous peer review the journal conducts for all unsolicited manuscripts. Peer review of Covid-19 manuscripts is steered by Massimo Filippi, one of the Chief Editors of Journal of Neurology. A related collection in the journal features articles on Long COVID-19 Syndrome.
Editors
-
Massimo Filippi, MD, PhD, Vita-Salute San Raffaele University, Italy
Massimo Filippi is Full Professor of Neurology at Università Vita-Salute San Raffaele, Milan, Italy; Director Residency School in Neurology; Chair of the Neurology Unit, Neurorehabilitation Unit and Neurophysiology Service and Director of the Neuroimaging Research Unit, Department of Neurology, IRCCS Ospedale San Raffaele, Milan. His research focuses on the definition of the mechanisms leading to progressive accumulation of irreversible physical disability and cognitive impairment in various neurological conditions. He is Chief Editor of the Journal of Neurology and responsible for the article collection on Covid-19.
Articles (251 in this collection)
-
-
Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome
Authors (first, second and last of 16)
-
The impact of COVID-19 infection, the pandemic and its associated control measures on patients with Pompe disease
Authors (first, second and last of 8)
-
-
Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months
Authors (first, second and last of 14)
-
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
Authors (first, second and last of 29)
-
Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results
Authors (first, second and last of 14)
-
Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review
Authors (first, second and last of 9)
-
-
Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies
Authors (first, second and last of 5)
-
-
Central nervous system complications in SARS-CoV-2-infected patients
Authors (first, second and last of 10)
-
Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis
Authors (first, second and last of 20)
-
Delirium in hospitalized COVID-19 patients: a prospective, multicenter, cohort study
Authors (first, second and last of 9)
-
Pediatric de novo movement disorders and ataxia in the context of SARS-CoV-2
Authors (first, second and last of 14)
-
Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression
Authors (first, second and last of 6)
-
-
The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting
Authors (first, second and last of 7)
-
Brain hypoxia, neurocognitive impairment, and quality of life in people post-COVID-19
Authors (first, second and last of 5)
-
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis
Authors (first, second and last of 38)
-
Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination
Authors (first, second and last of 6)
-
-
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore
Authors (first, second and last of 11)
-
Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in patients with COVID-19 infection: is there a link? A systematic review and case report analysis
Authors (first, second and last of 8)
-
Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report
Authors (first, second and last of 7)
-
COVID19-associated new-onset movement disorders: a follow-up study
Authors (first, second and last of 30)
-
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
Authors (first, second and last of 11)
-
Psychological impact of COVID-19 containment on CADASIL patients
Authors (first, second and last of 9)
-
Reduced cerebello-cerebral functional connectivity correlates with disease severity and impaired white matter integrity in Friedreich ataxia
Authors (first, second and last of 8)
-
Patterns of acute ischemic stroke and intracranial hemorrhage in patients with COVID-19
Authors (first, second and last of 34)
-
Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case–control study
Authors (first, second and last of 10)
-
MRI evidence of olfactory system alterations in patients with COVID-19 and neurological symptoms
Authors (first, second and last of 12)
-
The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register
Authors (first, second and last of 13)
-
Persistent hiccups as main COVID-19 manifestation with transient cytotoxic lesion of the corpus callosum splenium during the Omicron wave in the post-vaccination era
Authors (first, second and last of 9)
-
Vasculitic flare in a patient with anti-myelin-associated glycoprotein (MAG) antibody following mRNA-1273 SARS-CoV-2 vaccine
Authors (first, second and last of 5)
-
New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review
Authors (first, second and last of 5)
-
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic
Authors (first, second and last of 11)
-
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report
Authors (first, second and last of 11)
-
-
Structural brain changes in patients with persistent headache after COVID-19 resolution
Authors (first, second and last of 6)
-
Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis
Authors (first, second and last of 22)
-
Association of admission serum levels of neurofilament light chain and in-hospital mortality in geriatric patients with COVID-19
Authors (first, second and last of 20)
-
Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies
Authors (first, second and last of 7)
-
The late onset of emotional distress in people with progressive multiple sclerosis during the Covid-19 pandemic: longitudinal findings from the CogEx study
Authors (first, second and last of 19)
-
BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves
Authors (first, second and last of 7)
-
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
Authors (first, second and last of 12)
-
Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
Authors (first, second and last of 7)
-
Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry
Authors (first, second and last of 7)
-
SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19
Authors (first, second and last of 6)
-
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations
Authors (first, second and last of 13)
